Stress and atherosclerotic cardiovascular disease

Nobutaka Inoue1

  • 1Department of Cardiovascular Medicine, Kobe Rosai Hospital.

Insights

Stress, including oxidative, mental, hemodynamic, and social factors, plays a pivotal role in the complex pathogenesis of cardiovascular disease. Understanding these stress responses is crucial for developing new treatments for atherosclerosis-based conditions.

Area of Science:

  • Cardiovascular Science
  • Pathophysiology
  • Stress Medicine

Background:

  • Cardiovascular diseases (CVDs) remain a leading cause of death despite advances in treatment.
  • The pathogenesis of CVDs is complex, involving multiple contributing factors.
  • Stress is increasingly recognized as a pivotal factor in CVD development.

Purpose of the Study:

  • To explore the multifaceted roles of various types of stress in cardiovascular disease.
  • To elucidate the interactions between different stress pathways.
  • To discuss the pathophysiological and clinical implications of stress in atherosclerosis-based CVDs.

Main Methods:

  • Review of accumulating evidence on stress and cardiovascular disease.
  • Analysis of the impact of oxidative, mental, hemodynamic, and social stress.
  • Examination of the interplay between different stress types and their contribution to disease mechanisms.

Main Results:

  • Traditional risk factors like diabetes and hypertension induce oxidative stress.
  • Oxidative stress contributes to endothelial dysfunction, atherogenesis, and hypertension.
  • Mental, hemodynamic, and social stress are significant contributors to CVD development.
  • Interactions between stress types, such as mental and oxidative stress, exacerbate disease processes.

Conclusions:

  • Stress is a central player in the pathogenesis of atherosclerosis-based cardiovascular disease.
  • Understanding stress mechanisms and their interactions is vital for clinical practice.
  • Further research into stress management may offer new therapeutic avenues for CVD prevention and treatment.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
757
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K